GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » EV-to-EBITDA

Panion & Bf Biotech (TPE:1760) EV-to-EBITDA : 23.19 (As of Jun. 24, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Panion & Bf Biotech's enterprise value is NT$8,715 Mil. Panion & Bf Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was NT$376 Mil. Therefore, Panion & Bf Biotech's EV-to-EBITDA for today is 23.19.

The historical rank and industry rank for Panion & Bf Biotech's EV-to-EBITDA or its related term are showing as below:

TPE:1760' s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.11   Med: 25.33   Max: 471.19
Current: 23.19

During the past 13 years, the highest EV-to-EBITDA of Panion & Bf Biotech was 471.19. The lowest was 13.11. And the median was 25.33.

TPE:1760's EV-to-EBITDA is ranked worse than
73.75% of 461 companies
in the Biotechnology industry
Industry Median: 8.79 vs TPE:1760: 23.19

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-24), Panion & Bf Biotech's stock price is NT$99.20. Panion & Bf Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1.140. Therefore, Panion & Bf Biotech's PE Ratio for today is 87.02.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Panion & Bf Biotech EV-to-EBITDA Historical Data

The historical data trend for Panion & Bf Biotech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech EV-to-EBITDA Chart

Panion & Bf Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.01 41.54 19.36 30.45 27.95

Panion & Bf Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.01 38.77 43.03 27.95 25.66

Competitive Comparison of Panion & Bf Biotech's EV-to-EBITDA

For the Biotechnology subindustry, Panion & Bf Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panion & Bf Biotech's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panion & Bf Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Panion & Bf Biotech's EV-to-EBITDA falls into.



Panion & Bf Biotech EV-to-EBITDA Calculation

Panion & Bf Biotech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8715.405/375.794
=23.19

Panion & Bf Biotech's current Enterprise Value is NT$8,715 Mil.
Panion & Bf Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$376 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panion & Bf Biotech  (TPE:1760) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Panion & Bf Biotech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=99.20/1.140
=87.02

Panion & Bf Biotech's share price for today is NT$99.20.
Panion & Bf Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.140.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Panion & Bf Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Panion & Bf Biotech (TPE:1760) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 16th Floor, F Building, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. It is engaged in research and development of pharmaceuticals and new drugs. It focuses on pharmaceuticals, cosmeceuticals, nutraceuticals, and medical devices sectors. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generate majority of the revenue from Taiwan segment.

Panion & Bf Biotech (TPE:1760) Headlines

No Headlines